Avalyn Pharma Inc. — Investor Relations & Filings
Filings indexed
15
across all filing types
Latest filing
2026-05-09
Major Shareholding Noti…
Country
US
United States of America
Listing
—
AVLN
Avalyn Pharma Inc. is a clinical-stage biopharmaceutical company focused on developing innovative inhaled therapies for rare respiratory diseases. The company's primary focus is on pulmonary fibrosis, including Idiopathic Pulmonary Fibrosis, and other interstitial lung diseases, where there is a significant unmet medical need. Avalyn's approach involves creating new inhaled formulations of approved medicines, utilizing a nebulization method designed to directly target the lung. This strategy aims to improve the substantial tolerability issues often associated with existing oral treatment options, thereby enhancing patient outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2026 | 2026-05-09 | English | |
| Major Shareholding Notification 2026 | 2026-05-08 | English | |
| Major Shareholding Notification 2026 | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-05 | English | |
| 8-K | 2026-05-01 | English | |
| S-8 | 2026-04-30 | English |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46722384 | Major Shareholding Notification 2026 | 2026-05-09 | English | ||
| 46722385 | Major Shareholding Notification 2026 | 2026-05-08 | English | ||
| 46722389 | Major Shareholding Notification 2026 | 2026-05-07 | English | ||
| 46722386 | Major Shareholding Notification 2026 | 2026-05-05 | English | ||
| 46722393 | 8-K | 2026-05-01 | English | ||
| 46722402 | S-8 | 2026-04-30 | English | ||
| 46722419 | 424B4 | 2026-04-30 | English | ||
| 46722420 | Regulatory Filings 2026 | 2026-04-30 | English | ||
| 46722422 | Regulatory Filings 2026 | 2026-04-29 | English | ||
| 46722452 | S-1/A | 2026-04-29 | English | ||
| 46722454 | 8-A12B | 2026-04-27 | English | ||
| 46722465 | S-1/A | 2026-04-23 | English | ||
| 46722470 | S-1 | 2026-04-08 | English | ||
| 46722476 | Regulatory Filings 2026 | 2026-03-18 | English | ||
| 46722488 | Regulatory Filings 2026 | 2026-02-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ginkgo Bioworks Holdings, Inc.
Operates a horizontal platform for cell programming and syn…
|
DNA | US | Professional, scientific and te… |
|
GRAIL, Inc.
A healthcare company developing blood tests for multi-cance…
|
GRAL | US | Professional, scientific and te… |
|
GT Biopharma, Inc.
Clinical-stage immuno-oncology company developing therapies…
|
GTBP | US | Professional, scientific and te… |
|
Guard Therapeutics International AB
Clinical-stage biotech developing therapies to prevent acut…
|
GUARD | SE | Professional, scientific and te… |
|
Gubra A/S
Biotech and CRO focused on peptide drugs for metabolic and …
|
GUBRA | DK | Professional, scientific and te… |
|
HALOZYME THERAPEUTICS, INC.
Biopharmaceutical firm licensing technology to convert IV d…
|
HALO | US | Professional, scientific and te… |
|
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Provides integrated R&D and manufacturing services for chem…
|
301096 | CN | Professional, scientific and te… |
|
Hangzhou Tigermed Consulting Co., Ltd.
Leading global Contract Research Organization (CRO) for ful…
|
3347 | HK | Professional, scientific and te… |
|
Hangzhou Tigermed Consulting Co.,Ltd.
Provides clinical research solutions for pharmaceutical, bi…
|
300347 | CN | Professional, scientific and te… |
|
HEALIOS K.K.
Clinical-stage biotech developing regenerative medicine and…
|
4593 | JP | Professional, scientific and te… |
Avalyn Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72583/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72583 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72583 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72583 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72583}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Avalyn Pharma Inc. (id: 72583)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.